Biology Reference
In-Depth Information
[57] Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human
CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta
dependent but does not confer a regulatory phenotype. Blood 2007;110:2983-90.
[58] Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, Carlson MR, et al. A central role
for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol
2009;182:3461-8.
[59] Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, et al. A requisite
role for induced regulatory T cells in tolerance based on expanding antigen receptor
diversity. Immunity 2011;35:109-22.
[60] Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress poly-
clonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med
1998;188:287-96.
[61] McMurchy AN, Levings MK. Suppression assays with human T regulatory cells: a tech-
nical guide. Eur J Immunol 2012;42:27-34.
[62] Canavan JB, Afzali B, Scotta C, Fazekasova H, Edozie FC, Macdonald TT, et al. A rapid
diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.
Blood 2012;119:e57-66.
[63] Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an
essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal
inflammation. J Exp Med 2000;192:295-302.
[64] Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional delineation
and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription
factor. Immunity 2009;30:899-911.
[65] Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-
4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, reveal-
ing a critical negative regulatory role of CTLA-4. Immunity 1995;3:541-7.
[66] Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Distinct roles
of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol
2004;34:2996-3005.
[67] Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4
control over Foxp3+ regulatory T cell function. Science 2008;322:271-5.
[68] Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, et al. CTLA-4-Ig
regulates tryptophan catabolism in vivo. Nat Immunol 2002;3:1097-101.
[69] Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Cutting edge: IL-2 is critically
required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immu-
nol 2004;172:6519-23.
[70] Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity
2009;30:636-45.
[71] Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4(+)CD25(+)Foxp3(+) regula-
tory T cells induce cytokine deprivation-mediated apoptosis of effector CD4(+) T cells.
Nat Immunol 2007;8:1353-62.
[72] Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, et al. Cyclic
adenosine monophosphate is a key component of regulatory T cell-mediated suppres-
sion. J Exp Med 2007;204:1303-10.
[73] Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine genera-
tion catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune
suppression. J Exp Med 2007;204:1257-65.
[74] Davidson TS, Shevach EM. Polyclonal Treg cells modulate T effector cell trafficking. Eur
J Immunol 2011;41:2862-70.
[75] Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG. Natural killer T cells regulate
the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Hepatology 2009;49:1267-76.
[76] Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The tran-
scription factor T-bet controls regulatory T cell homeostasis and function during type 1
inflammation. Nat Immunol 2009;10:595-602.
[77] Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, et al. CD4+ regulatory
T cells control TH17 responses in a Stat3-dependent manner. Science 2009;326:986-91.
[78] Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT, et al. Regulatory T-cell sup-
pressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature
2009;458:351-6.
[79] Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regula-
tory T cells. Nat Rev Immunol 2011;11:119-30.
[80] Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+)
regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone
marrow transplantation. J Exp Med 2002;196:389-99.
265
Search WWH ::
Custom Search